NovX

About NovX

NovX Systems Corp., established in 2003 by founder Keith Beckley, operates primarily in the HealthTech sector, providing specialized software and hardware solutions for healthcare clinics. The company is headquartered in Richmond Hill, Ontario, Canada. NovX Systems was a venture-backed company that raised approximately $18.1 to $22.1 million over several funding rounds before being acquired by Qvella Corporation in March 2014, and now operates as a subsidiary.

The core of NovX Systems' business is its PatientVu™ electronic medical record (EMR) software, which is specifically designed for pain and addiction clinics in Canada. This software serves as a comprehensive case management tool, handling patient scheduling, appointments, notes, prescriptions, referrals, and billing. The business model appears to be centered on providing this tailored software solution to a niche market, with revenue generated from the clinics that use the platform. PatientVu™ aims to improve clinic efficiency by streamlining workflows and reducing redundant administrative tasks, allowing staff to focus more on patient care. A key feature is its integrated billing system that captures codes at each patient encounter for electronic submission to the Ministry of Health, which helps ensure accuracy and high recovery rates on billings.

The PatientVu™ platform offers several benefits to its client clinics. It is designed to be user-friendly, requiring minimal training for staff to become proficient. The software is informed by ongoing input from doctors, nurses, and office staff, ensuring it meets the specific needs of pain and addiction treatment centers. In addition to the desktop software, NovX offers PatientVu™ Mobile, an app for both iOS and Android that allows doctors to manage notes, calendars, and fax prescriptions directly from their mobile devices. The platform also includes analytics tools to help physicians and clinic owners make data-driven decisions. Alongside its EMR software, the company has also been described as a developer of drug-screening devices intended for use in non-laboratory settings by non-technical operators.